Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Wouter Plattel

19PUBLICATIONS

74CO-AUTHORS

Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursPredictive and prognostic markersHistorical, comparative and typological linguistics

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (19)

Sort by Publication Date:

|Apr 08, 2026

A phase 1/1b study of the BCMA-targeting bispecific T-cell engager pavurutamab for relapsed/refractory multiple myeloma.

Hans C Lee, Wouter J Plattel, Simon J Harrison

|Feb 04, 2026

Impact of rituximab maintenance on survival in patients with mantle cell lymphoma: a population-based cohort study.

Floriske G Stedema, Mirian Brink, Francien Huisman

|Dec 18, 2025

Dynamics of circulating tumour DNA in relapsed/refractory diffuse large B-cell lymphoma patients.

Yujie Zhong, Johanna Bult, Nick Veltmaat

|Jul 09, 2025

Treatment and outcome of breast implant-associated anaplastic large cell lymphoma: a population-based cohort study in the Netherlands.

Frederik O Meeuwes, Mirian Brink, Marjolein W M van der Poel

|Jun 20, 2025

Serum TARC: a biomarker for early detection or exclusion of relapse in classic Hodgkin lymphoma.

Sophie A Teesink, Lydia Visser, Marcel Nijland

|Apr 03, 2025

High-dose therapy followed by autologous stem cell transplantation emerges as the preferred salvage therapy in patients with limited-stage Hodgkin lymphoma progressing/relapsing after initial therapy: A subset analysis of the EORTC/LYSA/FIL H10 trial.

Gotti Manuel, Yana Stepanishyna, Tetiana Skrypets

Pageof 4

Frequent Collaborators

7 joint publications

Marcel Nijland

6 joint publications

Mirian Brink

5 joint publications

Joost S P Vermaat

4 joint publications

Pieternella J Lugtenburg

4 joint publications

Arjan Diepstra

4 joint publications

Martin Hutchings

3 joint publications

Berthe M P Aleman

3 joint publications

F J Sherida H Woei-A-Jin

3 joint publications

Richard W M van der Maazen

3 joint publications

Rimke Oostvogels

Frequent Collaborators

7 joint publications

Marcel Nijland

6 joint publications

Mirian Brink

5 joint publications

Joost S P Vermaat

4 joint publications

Pieternella J Lugtenburg

Top Related Videos

A Human Peripheral Blood Mononuclear Cell (PBMC) Engrafted Humanized Xenograft Model for Translational Immuno-oncology (I-O) Research

A Human Peripheral Blood Mononuclear Cell (PBMC) Engrafted Humanized Xenograft Model for Translational Immuno-oncology (I-O) Research

Published on : Aug 15, 2019

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma

Published on : Mar 30, 2018

Enhancing Tumor Content through Tumor Macrodissection

Enhancing Tumor Content through Tumor Macrodissection

Published on : Feb 12, 2022

See more related videos

Top Related Videos

A Human Peripheral Blood Mononuclear Cell (PBMC) Engrafted Humanized Xenograft Model for Translational Immuno-oncology (I-O) Research

A Human Peripheral Blood Mononuclear Cell (PBMC) Engrafted Humanized Xenograft Model for Translational Immuno-oncology (I-O) Research

Published on : Aug 15, 2019

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma

Published on : Mar 30, 2018

Enhancing Tumor Content through Tumor Macrodissection

Enhancing Tumor Content through Tumor Macrodissection

Published on : Feb 12, 2022

See more related videos